WO2009128738A3 - Utilisation de l'extrait de graines déshuilées de primevère - Google Patents

Utilisation de l'extrait de graines déshuilées de primevère Download PDF

Info

Publication number
WO2009128738A3
WO2009128738A3 PCT/PL2009/000035 PL2009000035W WO2009128738A3 WO 2009128738 A3 WO2009128738 A3 WO 2009128738A3 PL 2009000035 W PL2009000035 W PL 2009000035W WO 2009128738 A3 WO2009128738 A3 WO 2009128738A3
Authority
WO
WIPO (PCT)
Prior art keywords
extract
primrose
defatted
defatted seeds
seeds
Prior art date
Application number
PCT/PL2009/000035
Other languages
English (en)
Other versions
WO2009128738A2 (fr
Inventor
Marek Naruszewicz
Anna Kiss
Original Assignee
Warszawski Uniwersytet Medyczny
Agropharm S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warszawski Uniwersytet Medyczny, Agropharm S.A. filed Critical Warszawski Uniwersytet Medyczny
Publication of WO2009128738A2 publication Critical patent/WO2009128738A2/fr
Publication of WO2009128738A3 publication Critical patent/WO2009128738A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation de l'extrait de graines déshuilées de primevère pour préparer un agent destiné à prévenir ou à limiter des lésions du myocarde et des vaisseaux coronaires. On utilise de préférence l'extrait de graines déshuilées d'onagre (Oenothera paradoxa).
PCT/PL2009/000035 2008-04-18 2009-04-17 Utilisation de l'extrait de graines déshuilées de primevère WO2009128738A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL384978A PL215886B1 (pl) 2008-04-18 2008-04-18 Zastosowanie ekstraktu z odtluszczonych nasion wiesiolka
PLP-384978 2008-04-18

Publications (2)

Publication Number Publication Date
WO2009128738A2 WO2009128738A2 (fr) 2009-10-22
WO2009128738A3 true WO2009128738A3 (fr) 2010-06-10

Family

ID=41199606

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/PL2009/000035 WO2009128738A2 (fr) 2008-04-18 2009-04-17 Utilisation de l'extrait de graines déshuilées de primevère

Country Status (2)

Country Link
PL (1) PL215886B1 (fr)
WO (1) WO2009128738A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2829277A1 (fr) 2013-07-26 2015-01-28 Natac Biotech, S.L. Utilisation de proanthocyanidines de type a pour traiter une maladie liée au récepteur minéralocorticoïde
GB201413228D0 (en) 2014-07-25 2014-09-10 Nugerontix Ltd Polyphenol compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018416A1 (fr) * 1998-09-30 2000-04-06 Industrial Research Limited Compositions d'antioxydants et leur procede de preparation
CN1401339A (zh) * 2001-08-17 2003-03-12 中国科学院植物研究所 一种可降血脂、改善心肌缺血及心肌梗塞症状的口服液

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018416A1 (fr) * 1998-09-30 2000-04-06 Industrial Research Limited Compositions d'antioxydants et leur procede de preparation
CN1401339A (zh) * 2001-08-17 2003-03-12 中国科学院植物研究所 一种可降血脂、改善心肌缺血及心肌梗塞症状的口服液

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BALASINSKA BOZENA: "Hypocholesterolemic effect of dietary evening primrose (Oenothera paradoxa) cake extract in rats", FOOD CHEMISTRY, vol. 63, no. 4, December 1998 (1998-12-01), pages 453 - 459, XP002572236, ISSN: 0308-8146 *
DATABASE WPI Week 200347, Derwent World Patents Index; AN 2003-494214, XP002572238 *
DERWINSKA M ET AL: "Biological activity of extracts from defatted seeds of Oenothera paradoxa (Abstract P_476)", PLANTA MEDICA, August 2007 (2007-08-01), 55TH ANNUAL CONGRESS OF THE SOCIETY-FOR-MEDICINAL-PLANT-RESEARCH; GRAZ, AUSTRIA; SEPTEMBER 02 -06, 2007, XP002574820, Retrieved from the Internet <URL:https://www.thieme-connect.com/ejournals/abstract/plantamedica/doi/10.1055/s-2007-987256> [retrieved on 20100309], DOI: 10.1055/s-2007-987256 *
KISS ANNA K ET AL: "Novel biological properties of Oenothera paradoxa defatted seed extracts: effects on metallopeptidase activity.", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 56, no. 17, 10 September 2008 (2008-09-10), pages 7845 - 7852, XP002572239, ISSN: 1520-5118 *
LIU JU-CHI ET AL: "Antihypertensive effects of tannins isolated from traditional Chinese herbs as non-specific inhibitors of angiontensin converting enzyme.", LIFE SCIENCES 8 AUG 2003, vol. 73, no. 12, 8 August 2003 (2003-08-08), pages 1543 - 1555, XP002572237, ISSN: 0024-3205 *

Also Published As

Publication number Publication date
WO2009128738A2 (fr) 2009-10-22
PL215886B1 (pl) 2014-02-28
PL384978A1 (pl) 2009-10-26

Similar Documents

Publication Publication Date Title
EP3572414A4 (fr) Composé utilisé comme inhibiteur de la tyrosine kinase de bruton, son procédé de préparation et son application
WO2011153514A9 (fr) Utilisation d&#39;inhibiteurs de la tyrosine kinase de bruton (btk)
WO2012046030A3 (fr) Inhibiteurs de phosphodiestérase
WO2011032169A3 (fr) Compositions et formulations pharmaceutiques comprenant des inhibiteurs du domaine d&#39;homologie à la pleckstrine et leurs méthodes d&#39;utilisation
WO2007095124A3 (fr) Derives, compositions de benzazole et procedes d&#39;utilisation en tant qu&#39;inhibiteurs de la kinase aurora
WO2011077043A3 (fr) Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
EP2168570A3 (fr) Extraits d&#39;isochrysis sp.
WO2010149895A3 (fr) Extrait de graines entieres de moringa sp et son utilisation dans des compositions cosmetiques et/ou dermatologiques
EP2152279A4 (fr) Utilisation d&#39;un tensioactif biologique en tant qu&#39;agent anti-inflammatoire et solution de conservation de tissus
WO2009085889A3 (fr) Compositions et procédés pour réduire ou empêcher la perte d&#39;eau par la peau
WO2009141541A3 (fr) Utilisation d&#39; inhibiteurs de kif13a et d &#39; ap-1 pour inhiber la melanogenese
WO2012037299A3 (fr) Inhibiteurs de l&#39;acide gras synthase
WO2009099553A3 (fr) Utilisation d’inhibiteur de kinase pour le traitement de l’athérosclérose
WO2010077339A3 (fr) Effecteurs de la β-arrestine, compositions en contenant et leurs procédés d&#39;utilisation
EP3328380A4 (fr) Combinaisons d&#39;inhibiteur de la tyrosine kinase de bruton et leurs utilisations
WO2012024399A3 (fr) Compositions comprenant de la paulownine et/ou des extraits de paulownia et utilisations de celles-ci
WO2010090611A3 (fr) Compositions pharmaceutiques à l&#39;odeur et au goût masqués hautement biodisponibles
WO2009128738A3 (fr) Utilisation de l&#39;extrait de graines déshuilées de primevère
WO2012088382A3 (fr) Alcool d&#39;amyris et son ester pour le traitement de l&#39;acné
EP2898891A3 (fr) Extraits de terminalia chebula et terminalia bellerica pour l&#39;inhibition de la xanthine oxydase
WO2015055898A3 (fr) Compositions contenant des inhibiteurs de phosphodiestérase destinées au traitement d&#39;une tumeur solide chez un patient humain
WO2012031712A3 (fr) Instrument chirurgical
WO2011048011A3 (fr) Dérivés de benzotropolone à titre d&#39;agents antimicrobiens
WO2011067608A8 (fr) Traitement de l&#39;allodynie et de l&#39;hyperalgésie
AR082594A1 (es) Docosahexanoato de pantenilo y su uso para el tratamiento y prevencion de enfermedades cardiovasculares

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09732284

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09732284

Country of ref document: EP

Kind code of ref document: A2